BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29700308)

  • 1. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
    Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
    Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
    Guo Y; He X; Zhang M; Qu Y; Gu C; Ren M; Wang H; Ning W; Li J; Yu C; Zhang H
    J Neurooncol; 2020 Apr; 147(2):327-337. PubMed ID: 32170633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circBFAR promotes glioblastoma progression by regulating a miR-548b/FoxM1 axis.
    Li C; Guan X; Jing H; Xiao X; Jin H; Xiong J; Ai S; Wang Y; Su T; Sun G; Fu T; Wang Y; Guo S; Liang P
    FASEB J; 2022 Mar; 36(3):e22183. PubMed ID: 35202487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
    Wang Z; Zhang S; Siu TL; Huang S
    Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
    J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MYCNOS promotes glioblastoma cell proliferation by regulating miR-216b/FOXM1 axis.
    Zhao P; Li T; Wang Y; Wang Y; Gu Q; Li Z
    Metab Brain Dis; 2021 Aug; 36(6):1185-1189. PubMed ID: 33871770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
    Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
    J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
    Su X; Yang Y; Yang Q; Pang B; Sun S; Wang Y; Qiao Q; Guo C; Liu H; Pang Q
    BMC Cancer; 2021 Nov; 21(1):1181. PubMed ID: 34740322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
    Liu M; Dai B; Kang SH; Ban K; Huang FJ; Lang FF; Aldape KD; Xie TX; Pelloski CE; Xie K; Sawaya R; Huang S
    Cancer Res; 2006 Apr; 66(7):3593-602. PubMed ID: 16585184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells.
    Tao W; Zhang A; Zhai K; Huang Z; Huang H; Zhou W; Huang Q; Fang X; Prager BC; Wang X; Wu Q; Sloan AE; Ahluwalia MS; Lathia JD; Yu JS; Rich JN; Bao S
    EMBO Mol Med; 2020 Dec; 12(12):e12291. PubMed ID: 33124191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
    Gong AH; Wei P; Zhang S; Yao J; Yuan Y; Zhou AD; Lang FF; Heimberger AB; Rao G; Huang S
    Cancer Res; 2015 Jun; 75(11):2337-48. PubMed ID: 25832656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
    Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
    J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
    Zhang P; Chen X; Zhang L; Cao D; Chen Y; Guo Z; Chen J
    Cell Death Dis; 2022 Jan; 13(1):61. PubMed ID: 35039475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.